Part D Compliance: Formularies, Subsidies Will Be IG Enforcement Targets
The HHS Inspector General will be targeting formulary development, measurement of "true out of pocket" spending and employer subsidies in its oversight of the Medicare drug benefit
You may also be interested in...
The Centers for Medicare & Medicaid Services is waiving several Medicare Part D plan requirements for employers to provide maximum flexibility for their participation in the drug benefit
Pharmaceutical manufacturer patient assistance programs can be used to cover out-of-pocket costs for Medicare Part D enrollees, CMS says in its final implementing regulations for the drug benefit
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011